The Journey Begins

The Journey begins for you to create healing and wellness. Thanks for joining me!

Good company in a journey makes the way seem shorter. — Izaak Walton

Your healing and wellness is the priority! You are not alone on this great journey. Decrease your stress and do your best to achieve your goals! Decreasing stress will allow your immune system to function more efficiently. Slow and steady every day; eat healthy, take your protocol, exercise or walk daily and reach your goals for healing!

On a daily basis you are helping yourself by taking your personalized protocol to target the cancer cells through the metabolic pathways. This will starve the cancer cells of the nutrients that they require to continue to grow and inhibit the cancer stem cells that cause the spread of the cancer. Every day the cancer cells are being stopped! Slow and steady wins the race!!

MEDICAL NEWS: Statins ‘block an enzyme thought to trigger ovarian cancer’

New scientific evidence to support that statins may have the power to decrease ovarian cancer risk. These medications are prescribed to millions to lower cholesterol by targeting and blocking an enzyme in the body. Now, a study has found women who naturally have lower levels of the enzyme HMG-CoA reductase have a 40 per cent lower risk of ovarian cancer. The scientists said their findings suggest the inexpensive pills, have cancer fighting abilities. 

More than 4,100 woman a year die from ovarian cancer, known as the ‘silent killer’ because of its vague symptoms and no screening methods. This makes preventing ovarian cancer very difficult. 

The cholesterol lowering pills block an enzyme which has shown to be protective against the ovarian cancer in low levels. The researchers looked at 63,347 women between the ages of 20 and 100 years old from across the world. Participants were enrolled in cohorts between 1973 and 2014, and were followed to 2015. They found that 22,406 had ovarian cancer.  They also looked at an additional 31,448 women who carried the BRCA1/2 genes, of whom 3,887 had ovarian cancer.  More than four in 10 women with BRCA1 gene, and less than two in 10 women with BRCA2 gene are estimated to develop ovarian cancer by age 80. 

The research published in JAMA did not look at the risk of ovarian cancer between those who take statins and those who do not. Instead, scientists studied genes and the extent to which they naturally block the enzyme HMG-CoA reductase. Women who are genetically wired to inhibit HMG-CoA to reduced levels had a 40 per cent lower risk of ovarian cancer. The estimated reduction was slightly lower for women who carry the BRCA1/2 gene fault, at 30 per cent.

Because the estimates comes from looking at gene variation, rather than statins themselves, the exact mechanism behind the lowered ovarian risk is unclear at this point.  Professor Richard Martin, from the University of Bristol, said: ‘It’s incredibly interesting that women whose bodies naturally inhibit the enzyme targeted by statins have a lower risk of ovarian cancer, but we don’t recommend anyone rushes to take statins specifically to reduce ovarian cancer risk because of this study. 

‘It’s a promising result and I hope it sparks more research and trials into statins to demonstrate conclusively whether or not there’s a benefit. Our findings open up the possibility of repurposing a cheap drug to help prevent ovarian cancer, especially in women who are at a higher risk.’ 

Previous observational studies have reported lower rates of ovarian cancer among people who take statins compared to non-users.  Stains have been shown to induce apoptosis – one of the body’s ways of getting rid of old, faulty cells (such as cancer cells).  They have also been found to stop tumors from growing in laboratory studies for many years. 

Incredible new information about repurposed medications regrading the possibility of cancer prevention. The ability to induce apoptosis of cancer cells with repurposed medications has been studied for many, many years and the evidence is ever mounting. This helps our journey to gain momentum!!

EVERY DAY IS A BEAUTIFUL DAY TO SAVE LIVES.

THE OPPORTUNITY TO EMPOWER PATIENTS TO HELP THEMSELVES, LEARN ABOUT & USE “REPURPOSED” OR “OFF-LABEL” MEDICATIONS AS ADJUNCT TREATMENT UNDER PHYSICIAN SUPERVISION SAVES LIVES. ADJUNCT TREATMENT IS ALLOWING PATIENTS TO GET BETTER RESULTS THAN STANDARD OF CARE ALONE.

JOIN THE JOURNEY TODAY. 

FOR MORE INFORMATION, PLEASE CONTACT ME.

GRATEFULLY, WE HAVE ACCESS TO ALL REPURPOSED MEDICATIONS OR OFF-LABEL DRUGS INCLUDING MEBENDAZOLE THROUGHOUT THE PANDEMIC!!